ADPT
Adaptive Biotechnologies Corporation
Halal Rating :
See Details
Last Price
$3.51
Last updated:
Market Cap
$396.42m
7D Change
16.61%
1 Year Change
-48.31%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Feb. 14, 2024
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.
Use of Interest
Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
March 31, 2024 | $38.88m | $147.64m | - | $2.99m | 0.00% | 2.03% |
Dec. 31, 2023 | $42.77m | $188.3m | $4.61m | $3.01m | 10.79% | 1.60% |
Sept. 30, 2023 | $34.27m | $133.52m | $4.28m | $3.65m | 12.50% | 2.74% |
Company Impact
Help us evaluate Adaptive Biotechnologies Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.